4.1 Article

miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy

Journal

TUMOR BIOLOGY
Volume 37, Issue 2, Pages 2425-2433

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1007/s13277-015-3966-1

Keywords

NPC; CDK4; miR-16; c-Myc; Feedback loop

Categories

Funding

  1. National Nature Science Fund of China [30971438, 81102061]
  2. New Star Plan of Pearl River Science and Technology from Guangzhou City [2011J2200009]
  3. Guangdong Science and Technology Planning Project [2014A020212342]
  4. Yangcheng Scholar Research Projects from Universities of Guangzhou [12A011D]
  5. Oustanding Young Teacher Training Project of Collegues and Universities in GuangDong Province [Yp2013136]
  6. Guangzhou Science and Technology Planning Project [2013J4100035]
  7. Ph.D. Programs Foundation of Ministry of Education of China [20134423110001]

Ask authors/readers for more resources

Cyclin-dependent kinase 4 (CDK4) is a member of cyclin-dependent kinase family which regulates G1 to S cell cycle transition. CDK4 activity is increased in many tumor types. Here, we report a negative automodulatory feedback loop between CDK4 and miR-16 that regulates cell cycle progression in nasopharyngeal carcinoma (NPC). By miRNA array and real-time PCR, we identified upregulation of tumor suppressor miR-16a, which inhibited cell cycle progression and sensitized NPC cells to chemotherapy. CDK4 knockdown reduced the expression of c-Myc, the latter of which directly suppresses the miR-16 expression by directly binding to the miR-16 promoter. Moreover, we found that miR-16 upregulation could reduce CDK4 expression by repressing CCND1 and thus forms a feedback loop via the CDK4/c-Myc/miR-16/CCND1 pathway. Finally, miR-16 was negatively correlated with CDK4 expression in NPC biopsies. In summary, our results define a double-negative feedback loop involving CDK4 and miR-16 mediated by c-Myc that modulates NPC cell growth and chemotherapy sensitivity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available